Caged Hapten Proximity Assay for Reliable FFPE Protein Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting protein-protein interactions in formalin-fixed, paraffin-embedded (FFPE) tissues are not effective or reliable, particularly due to the high cost and incompatibility with automated systems of enzymes like DNA ligases and Phi29 DNA polymerase, limiting their practical use in commercial applications.
Innovation Solution
A method using caged hapten-antibody conjugates and unmasking enzymes to detect proximity of targets in a sample, involving the formation of enzyme-substrate complexes for signal amplification, enabling detection of protein dimers and total protein levels through chromogenic or fluorescent substrates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If proximity ligation assay uses DNA ligases and Phi29 DNA polymerase for detection, then detection capability is achieved, but cost increases and compatibility with automated systems is lost
Solution Approach 1:
The patent replaces expensive enzymes (DNA ligase and Phi29 DNA polymerase) with inexpensive, stable reagents including caged hapten-antibody conjugates, unmasking enzymes, and chromogenic/fluorogenic substrates. These alternative reagents achieve the same detection function at lower cost and with compatibility for automated processing systems.
Solution Approach 2:
The patent fundamentally changes the detection mechanism from enzyme-based DNA amplification to a chemistry-based signal generation system using caged haptens and unmasking enzymes. This parameter change enables the assay to function without expensive, temperature-sensitive enzymes while maintaining detection sensitivity and enabling automation.
2Measurement precision
If signal amplification is increased to detect low-abundance markers, then detection sensitivity is improved, but background noise and false positives increase
Solution Approach 1:
The patent applies preliminary action by using caged haptens that are initially inactive and only become detectable after proximity-induced unmasking. This ensures that signal generation occurs only when targets are in close proximity, reducing background noise and false positives while maintaining high sensitivity for low-abundance markers.
Solution Approach 2:
The patent introduces an intermediary mechanism (caged hapten unmasking) that acts as a gatekeeper between target binding and signal generation. The unmasking step requires specific proximity conditions to be met, serving as a verification step that reduces false positives while enabling signal amplification for true positive detections.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables reliable and cost-effective detection of protein-protein interactions in FFPE tissues, suitable for automated systems, with enhanced sensitivity and specificity for low-abundance cellular markers, facilitating diagnostic applications.
Implementation Method 1
contacting the sample with a caged hapten-antibody conjugate specific to a first target to form a first target-caged hapten-antibody conjugate complex; contacting the sample with an unmasking enzyme-antibody conjugate specific to a second target to form a second target-unmasking enzyme-antibody conjugate complex
Implementation Method 2
enabling detection of protein dimers and total protein levels through chromogenic or fluorescent substrates
Implementation Method 3
enabling detection of protein dimers and total protein levels through chromogenic or fluorescent substrates
Data Source
AI summary
Disclosed herein are caged haptens and caged hapten-antibody conjugates useful for enabling the detection of targets located proximally to each other in a sample.